The University of Utah Hospital is a research and teaching hospital on the campus of the University of Utah in Salt Lake City, Utah. It serves as a major regional referral center for Utah and the surrounding states of Idaho, Nevada, Wyoming, Montana and New Mexico.

There are 425 beds in University of Utah Health Sciences Center.

During the past decade, University of Utah Health Sciences Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 39 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 18 clinical trials were completed. i.e. 138.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah Health Sciences Center" #1 sponsor was "Radiation Therapy Oncology Group" with 32 trials, followed by "University of Utah" with 20 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored, "Baxalta now part of Shire" with 3 trials sponsored and "University of Minnesota" with 3 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah Health Sciences Center" are "Head and Neck Cancer" (7 trials), "Lung Cancer" (6 trials), "Prostate Cancer" (5 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Metastatic Cancer" (4 trials). Many other conditions were trialed in "University of Utah Health Sciences Center" in a lesser frequency.

Most popular intervention types in "University of Utah Health Sciences Center" are "Drug" (76 trials), "Radiation" (29 trials), "Procedure" (17 trials), "Biological" (12 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (30 trials), "Placebo" (18 trials), "cisplatin" (8 trials), "conventional surgery" (8 trials) and "paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah Health Sciences Center" are 107 trials for "All" genders, 7 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "University of Utah Health Sciences Center". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in University of Utah Health Sciences Center, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah Health Sciences Center, 9 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 17 trials that are defined as “Not Applicable".